Back
Corporate News
Nectar Lifesciences confirms regulatory compliance with filings to Indian stock exchanges
06-Oct-2026, 12:03
Nectar Lifesciences Limited submitted a certificate to the National Stock Exchange of India Limited and BSE Limited on October 6, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, and received from Kfin Technologies Limited, the company’s registrar and share transfer agent, for the quarter ended September 30, 2026.
